Engler Robert L Md - Net Worth and Insider Trading
Engler Robert L Md Net Worth
The estimated net worth of Engler Robert L Md is at least $17 Million dollars as of 2024-11-11. Engler Robert L Md is the Director of Halozyme Therapeutics Inc and owns about 273,176 shares of Halozyme Therapeutics Inc (HALO) stock worth over $17 Million. Details can be seen in Engler Robert L Md's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Engler Robert L Md has not made any transactions after 2014-08-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Engler Robert L Md
Engler Robert L Md Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Engler Robert L Md owns 1 companies in total, including Halozyme Therapeutics Inc (HALO) .
Click here to see the complete history of Engler Robert L Md’s form 4 insider trades.
Insider Ownership Summary of Engler Robert L Md
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2014-08-14 | director |
Engler Robert L Md Latest Holdings Summary
Engler Robert L Md currently owns a total of 1 stock. Engler Robert L Md owns 273,176 shares of Halozyme Therapeutics Inc (HALO) as of August 14, 2014, with a value of $17 Million.
Latest Holdings of Engler Robert L Md
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| HALO | Halozyme Therapeutics Inc | 2014-08-14 | 273,176 | 61.01 | 16,666,468 |
Holding Weightings of Engler Robert L Md
Engler Robert L Md Form 4 Trading Tracker
According to the SEC Form 4 filings, Engler Robert L Md has made a total of 0 transactions in Halozyme Therapeutics Inc (HALO) over the past 5 years. The most-recent trade in Halozyme Therapeutics Inc is the sale of 35,000 shares on August 14, 2014, which brought Engler Robert L Md around $348,600.
Insider Trading History of Engler Robert L Md
- 1
Engler Robert L Md Trading Performance
GuruFocus tracks the stock performance after each of Engler Robert L Md's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Engler Robert L Md is 13.23%. GuruFocus also compares Engler Robert L Md's trading performance to market benchmark return within the same time period. The performance of stocks bought by Engler Robert L Md within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Engler Robert L Md's insider trading performs compared to the benchmark.
Performance of Engler Robert L Md
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.1 | | | | | |
| Relative Return to S&P 500(%) | 19.78 | | | | | |
Engler Robert L Md Ownership Network
Ownership Network List of Engler Robert L Md
Ownership Network Relation of Engler Robert L Md
Engler Robert L Md Owned Company Details
What does Halozyme Therapeutics Inc do?
Who are the key executives at Halozyme Therapeutics Inc?
Engler Robert L Md is the director of Halozyme Therapeutics Inc. Other key executives at Halozyme Therapeutics Inc include SVP & Chief Technical Officer Michael J. Labarre , director & President and CEO Helen Torley , and SVP & Chief Financial Officer Nicole Labrosse .
Halozyme Therapeutics Inc (HALO) Insider Trades Summary
Over the past 18 months, Engler Robert L Md made no insider transaction in Halozyme Therapeutics Inc (HALO). Other recent insider transactions involving Halozyme Therapeutics Inc (HALO) include a net sale of 280,000 shares made by Michael J. Labarre , a net sale of 200,000 shares made by Helen Torley , and a net sale of 49,881 shares made by Matthew L. Posard .
In summary, during the past 3 months, insiders sold 199,881 shares of Halozyme Therapeutics Inc (HALO) in total and bought 0 shares, with a net sale of 199,881 shares. During the past 18 months, 584,881 shares of Halozyme Therapeutics Inc (HALO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 584,881 shares.
Halozyme Therapeutics Inc (HALO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Halozyme Therapeutics Inc Insider Transactions
Engler Robert L Md Mailing Address
Above is the net worth, insider trading, and ownership report for Engler Robert L Md. You might contact Engler Robert L Md via mailing address: C/o Collateral Therapeutics, 11622 El Camino Real, San Diego Ca 92130.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
